文献速递认知障碍与痴呆

额颞叶痴呆综合征中的声学改变言语感知

Acoustically Altered Speech Perception in Frontotemporal Dementia Syndromes.
PubMed 文献 · Neurology · 2025-09-11

这项横断面病例对照研究纳入29例额颞叶痴呆(FTD)患者和15名年龄匹配对照,采用纯音测听和三项声学改变言语(AAS)感知测试评估听觉。结果显示,非流利/语法缺失变异原发性进行性失语(nfvPPA)患者在频谱滤波言语和时间压缩言语测试中表现最差,且AAS感知与真实世界听力障碍的相关性高于纯音测听阈值。

要点

  • nfvPPA患者的纯音测听阈值显著高于对照,提示外周听力损失更明显。
  • nfvPPA患者在频谱滤波言语和时间压缩言语测试中表现显著差于其他组。
  • 语义变异PPA患者的时间压缩言语表现显著差于对照。

核心结论

  • 声学改变言语感知可区分FTD综合征亚型,并可作为这些疾病的「真实世界听力图」。

研究设计与样本

  • 横断面病例对照研究,在英国三级中心招募符合诊断标准的FTD和原发性进行性失语综合征患者。
  • 共纳入44名参与者,平均年龄66岁(SD 6.23),女性13人(29.5%)。
  • 29例FTD患者(nfvPPA 6例、svPPA 8例、bvFTD 15例)与15名年龄匹配对照进行比较。
  • 参与者完成纯音测听和3项AAS感知测试(噪声中言语、频谱滤波言语、时间压缩言语),并通过mAIAD评估真实世界听力能力。

主要发现

  • nfvPPA患者平均纯音测听阈值显著高于对照(平均差12分贝,95%CI 0.7-23.4,p=0.034)。
  • nfvPPA患者在频谱滤波言语测试中显著差于所有其他组(vs 对照:差6.3,95%CI 9.4-3.1,p<0.001;vs svPPA:差2.4,95%CI 0.5-7.3,p=0.0018;vs bvFTD:差2.0,95%CI 1.45-7.0,p=0.0012)。
  • nfvPPA患者在时间压缩言语测试中显著差于对照和bvFTD患者(vs 对照:差88.2,95%CI 29.7-146.7,p<0.01;vs bvFTD:差76.1,95%CI 26.7-125.5,p<0.01)。
  • svPPA患者在时间压缩言语测试中显著差于对照(差57.4,95%CI 16.38-98.4,p=0.01)。
  • nfvPPA和svPPA患者的mAIAD评分显著差于对照(nfvPPA差27.2,95%CI 9.3-45.2,p<0.001;svPPA差25.7,95%CI 11.8-39.5,p=0.0013)。

临床怎么用

  • 对FTD患者,尤其是nfvPPA和svPPA亚型,应关注声学改变言语感知障碍,而不仅依赖纯音测听。
  • AAS测试可作为评估真实世界听力症状的工具,帮助识别日常聆听困难。

局限性

  • 样本量较小(44例),各亚组例数有限。
  • 横断面设计无法确定因果关系。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Hearing impairment is a major clinical issue in dementia. Acoustically altered speech (AAS) is a typical real-world listening challenge, but markers of AAS perception, especially in frontotemporal dementias (FTDs), remain undefined. We investigated whether AAS perception differentiates FTD syndromes and predicts real-world hearing symptoms. METHODS: In this cross-sectional case-control study, participants meeting diagnostic criteria for FTD and primary progressive aphasia syndromes were recruited at a UK tertiary center. Participants performed pure-tone audiometry (PTA) and 3 AAS perception tests: speech-in-babble (SIB), spectrally filtered speech (SFS), and time-compressed speech (TCS). Real-world hearing abilities were assessed through the modified Amsterdam Inventory for Auditory Disability and Handicap (mAIAD). Group characteristics were compared using analysis of variance and Fisher exact tests. Regression models adjusted for PTA and Wechsler Abbreviated Scale of Intelligence Matrices scores compared group performance on AAS tests. The Spearman test examined correlations with mAIAD scores. RESULTS: Among 44 participants, the mean (SD) age was 66 (6.23) years and 13 (29.5%) were female. 29 patients with FTD (6 with nonfluent/agrammatic variant PPA [nfvPPA], 8 with semantic variant PPA [svPPA], and 15 with behavioral variant FTD [bvFTD]) were compared with 15 age-matched controls. Patients with nfvPPA had significantly higher mean PTA thresholds than controls (mean difference 12 decibels [95% CI 0.7-23.4], p = 0.034). Those with nfvPPA performed significantly worse on the SFS test than all other groups (vs controls: difference 6.3 [9.4-3.1], p < 0.001; vs svPPA group: difference 2.4 [0.5-7.3], p = 0.0018; vs bvFTD group: difference 2.0 [1.45-7.0], p = 0.0012) and significantly worse on the TCS test than controls and patients with bvFTD (vs controls: difference 88.2 [29.7-146.7], p < 0.01; vs bvFTD group: difference 76.1 [26.7-125.5], p < 0.01). The svPPA group performed significantly worse than controls on TCS (difference 57.4 [16.38-98.4], p = 0.01). Patients with nfvPPA (difference 27.2 [9.3-45.2], p < 0.001) and svPPA (difference 25.7 [11.8-39.5], p = 0.0013) had significantly worse mAIAD scores than controls. Over the combined patient cohort, mAIAD scores correlated more strongly with AAS than PTA thresholds (TCS, ρ = 0.64, p < 0.001; SFS, ρ = 0.53, p = 0.003; SIB, ρ = 0.5, p = 0.004; PTA, ρ = 0.37, p = 0.028). DISCUSSION: AAS perception stratifies FTD syndromes and constitutes a "real-world audiogram" in these diseases.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Johnson JCS, Jiang J, Requena-Komuro MC, et al. Acoustically Altered Speech Perception in Frontotemporal Dementia Syndromes. Neurology. 2025. PMID: 40934459. doi:10.1212/WNL.0000000000214022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。